Insider Stock Trading History of Halstead Michael


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Halstead Michael since year 2005. The trader's CIK number is 1521548. At the time of this reporting, Halstead Michael is the SVP and General Counsel of Intra-cellular Therapies, Inc. . (stock ticker symbol NONE). See this page for all insider trading activities at Intra-cellular Therapies, Inc. .

Note that in the past Halstead Michael also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Halstead Michael since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-01-05 ITCI Intra-cellular Therapies, Inc. Sale 1,601 16.55 26,496
2017-01-04 ITCI Intra-cellular Therapies, Inc. Option Ex 3,107 .00 0
2014-11-05 ITCI Intra-cellular Therapies, Inc. Buy 7,000 15.21 106,470
2014-11-06 ITCI Intra-cellular Therapies, Inc. Buy 13,000 15.47 201,110
2013-07-01 WCRX Warner Chilcott Ltd Sale 366 19.88 7,276
2013-02-28 WCRX Warner Chilcott Ltd Sale 1,747 13.46 23,521
2013-02-19 WCRX Warner Chilcott Ltd Sale 419 14.53 6,087
2013-02-01 WCRX Warner Chilcott Ltd Sale 998 14.18 14,149
2013-01-30 WCRX Warner Chilcott Ltd Sale 320 13.38 4,282
2013-01-22 WCRX Warner Chilcott Ltd Sale 488 13.50 6,588
2012-10-01 WCRX Warner Chilcott Ltd Sale 77 13.55 1,043
2012-07-02 WCRX Warner Chilcott Ltd Sale 355 17.96 6,375
2012-03-01 WCRX Warner Chilcott Ltd Sale 725 17.00 12,324
2012-02-21 WCRX Warner Chilcott Ltd Sale 409 16.82 6,880
2012-01-30 WCRX Warner Chilcott Ltd Sale 320 16.45 5,264
2012-01-23 WCRX Warner Chilcott Ltd Sale 487 17.32 8,434
2012-01-11 WCRX Warner Chilcott Ltd Sale 452 16.66 7,530
2011-10-03 WCRX Warner Chilcott Ltd Sale 78 14.03 1,094

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Halstead Michael (SVP and General Counsel of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.